Stock Market Listing

Logistics services provider Shadowfax is set to launch its Rs 1,900-crore initial public offering (IPO) next week, targeting a valuation of Rs 7,400 crore, people familiar with the matter said on Monday. The company is expected to announce the price band of its maiden public offering this week, they added. People familiar with the matter told PTI that Shadowfax is targeting a post-market valuation of about Rs 7,400 crore, lower than previous estimates of Rs 8,500 crore, in what is being positioned as a more conservative pricing approach aimed at attracting long-term institutional investors. They said the proposed IPO will comprise fresh issue of shares worth Rs 1,000 crore and an offer for sale (OFS) of Rs 900 crore by existing shareholders. As a part of the OFS, Flipkart Internet, Eight Roads Investments Mauritius II Ltd, NewQuest Asia Fund IV (Singapore) Pte. Ltd, Nokia Growth Partners IV, L.P, International Finance Corporation, Mirae Asset ,Qualcomm Asia Pacific Pte. Ltd and ...

Following the listing, E to E Transportation stock reached a high of ₹347.10 per share, hitting a 5 per cent upper circuit

Dhara Rail Projects shares were listed at ₹150 apiece, representing a 19 per cent premium over the issue price of ₹126 per share

Pre-listing shareholder lock-ins in 101 companies will be lifted between December 29, 2025, and March 2026, covering shares worth $23 billion, though not all may hit the market

KSH International shares opened at ₹370 on the NSE, a discount of ₹14 or 3.7 per cent from the issue price of ₹384

The IPO market, which scaled a record high in 2025 with companies raising an unprecedented Rs 1.76 lakh crore, driven by abundant domestic liquidity, resilient investor confidence and supportive macroeconomic factors, is expected to carry that momentum into the New Year. This exceptional year not only reflected issuers' confidence but also highlighted investors' eagerness to chase listing-day gains and back companies with strong long-term growth potential. A major highlight of the year was the resurgence of startup listings with as many as 18 startups, including Lenskart, Groww, Meesho and PhysicsWallah, going public and collectively raising over Rs 41,000 crore. In 2024, startups raised Rs 29,000 crore from the primary market. This rebound signals a reset in valuation expectations and business models after a period of caution. At the same time, Offer for Sale (OFS) continued to dominate fundraising activity, accounting for about 60 per cent of total capital raised in 2025. Overal

KSH International IPO witnessed underwhelming response from investors, getting oversubscribed only 83 per cent overall

Domestic brokerages Equirus Securities and PL Capital have initiated coverage on ICICI Prudential Asset Management Company

ICICI Prudential AMC shares listed at ₹2,600 on the NSE, a premium of ₹435 or 26 per cent from the issue price of ₹2,165

Park Medi World shares opened at ₹158.80 on the NSE, a discount of ₹3.2 or 2 per cent from the issue price of ₹162

Corona Remedies shares opened at ₹1,470 on the NSE, a premium of ₹408 or 38 per cent from the issue price of ₹1,062

Corona Remedies IPO received an overwhelming investor interest, achieving an overall oversubscription of 137 times, driven largely by strong participation from QIBs

Analysts suggest investors to hold for long term, citing the company's strong positioning as one of India's most advanced aerospace precision-manufacturing platforms

Choice Equity Broking has initiated coverage on Meesho with a 'Buy' rating, citing the company's structural competitive Moats, strong monetisation runway, and accelerating path to profitability

Ahead of debut, Vidya Wires shares were quoting at ₹55.5 in the grey market, reflecting a premium of ₹3.5 or 6.7 per cent over the issue price

Ahead of its listing, the unlisted shares of Aequs were trading at around ₹152 per share in the grey market, indicating a premium of ₹28 or 22.6 per cent

Overall subscription for Meesho IPO was strong at 79.03 times, with total bids at 21.96 billion shares against the 277.93 million shares on offer

Meesho's IPO was subscribed 2.4 times on the first day, driven by strong retail demand, after it raised Rs 2,440 crore from anchors and set a price band of Rs 105-111 per share

Sudeep Pharma shares opened at ₹733.95, a premium of ₹140.95 or 23.8 per cent

Sudeep Pharma IPO witnessed robust investor interest, getting oversubscribed 93.72 times overall, driven largely by strong participation from QIBs